- Home
- CETY vs APRE Comparison
CETY vs APRE Comparison
Compare CETY & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CETY | APRE |
|---|---|---|
| Founded | 1993 | 2006 |
| Country | United States | United States |
| Employees | 24 | 8 |
| Industry | Power Generation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 8.4M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CETY | APRE |
|---|---|---|
| Price | $0.86 | $0.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | ★ 1.1M | 231.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.97 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $957,633.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.18 | $0.55 |
| 52 Week High | $3.05 | $2.65 |
Technical Indicators
Market Signals| Indicator | CETY | APRE |
|---|---|---|
| Relative Strength Index (RSI) | 51.07 | 41.59 |
| Support Level | $0.81 | $0.55 |
| Resistance Level | $0.85 | $0.98 |
| Average True Range (ATR) | 0.11 | 0.08 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 25.53 | 2.44 |
Price Performance
Historical ComparisonAbout CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.
About APRE Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.